NanoString Technologies

  NSTG logo 355x90  

Drug Discovery and Development

3 Discovery-PreClinical 501x198 Avoiding costly missteps in drug development requires well-validated biomarkers that play a critical role in every stage, from initial identification of candidate drug, translational research, clinical development, and reverse translational studies. NanoString’s platforms facilitate efficient biomarker discovery and validation throughout all stages. Whether you require bulk, single-cell or sub-cellular spatial analysis, their innovative technologies can accelerate your discoveries in drug development.

Accelerate and De-risk Biomarker Discovery and Drug Development

3 BiomarkerDiscovery 1274x309
nCounter® Pro Analysis System

Up to 800-plex Pathway Based Gene Expression Tissues, FFPE, Biofluids
GeoMx® Digital Spatial Profiler

Morphological, spatial context for whole transcriptome and proteomics experiments from a single slide
CosMx™ Spatial Molecular Imager

Single cell profiling of RNA and proteins with subcellular resolution